ApaTech steps up US synthetic bone graft drive
This article was originally published in Clinica
UK synthetic bone graft developer ApaTech is stepping up for the next stage in its own development with the establishment of US operations. The London, UK-based spin-out of Queen Mary University recently obtained FDA 510(k) clearance for its Pore-Si and ApaPore products, and is aiming to "capture significant market share in the US", according to ApaTech Inc's new president, Steve Czick.
You may also be interested in...
Revised bill released by the US Senate Finance Committee adjusts the manufacturer discount program in Medicare Part D and includes new provisions aimed at easing beneficiary cost sharing obligations.
Through a draft guidance, the US agency has established performance criteria for magnetic resonance coils, making the devices eligible for the standards-based Safety and Performance Based Pathway.
Singapore recalls trigger international reaction as metformin is added to growing list of chronic medications found to contain NDMA.